Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ACIFOL FE is an oral antianemic combination drug developed and marketed by Laboratorio Domínguez. It contains iron polymaltose (providing elemental iron), folic acid (vitamin B9), and cyanocobalamin (vitamin B12). This combination is indicated for the prevention and treatment of iron deficiency anemia and nutritional anemias, particularly during periods of increased demand such as pregnancy and lactation. Iron polymaltose provides a stable, non-ionic source of iron that is highly bioavailable and well-tolerated, while folic acid and cyanocobalamin are essential cofactors for erythropoiesis and DNA synthesis, supporting the maturation of red blood cells.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on cyanocobalamin + folic acid + iron polymaltose.